Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Intellipharmaceutics International Inc (IPCIF)

Intellipharmaceutics International Inc (IPCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results Newswire.ca - Tue Jun 6, 2023

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCI.TO : 0.0800 (-11.11%)
IPCIF : 0.0001 (-99.93%)
Intellipharmaceutics Announces Cease Trade Order Newswire.ca - Tue Mar 7, 2023

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCI.TO : 0.0800 (-11.11%)
IPCIF : 0.0001 (-99.93%)
Intellipharmaceutics Provides Update on Management Cease Trade Order Application and Anticipates Cease Trade Order Newswire.ca - Tue Feb 7, 2023

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCI.TO : 0.0800 (-11.11%)
IPCIF : 0.0001 (-99.93%)
Intellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form and its Management Cease Trade Order Application Newswire.ca - Mon Feb 6, 2023

/CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in...

IPCI.TO : 0.0800 (-11.11%)
IPCIF : 0.0001 (-99.93%)
Intellipharmaceutics Announces Second Quarter 2022 Results ACCESS Newswire - Thu Jul 21, 2022

TORONTO, ON / ACCESSWIRE / July 21, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research,...

IPCI.TO : 0.0800 (-11.11%)
IPCIF : 0.0001 (-99.93%)
Intellipharmaceutics Announces Delay in Filing Second Quarter Results Due July 15, 2022, The Financial Statements Will be Filed By July 21, 2022 ACCESS Newswire - Fri Jul 15, 2022

TORONTO, ON / ACCESSWIRE / July 15, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research,...

IPCI.TO : 0.0800 (-11.11%)
IPCIF : 0.0001 (-99.93%)
Intellipharmaceutics Reports Director Election Results ACCESS Newswire - Fri May 27, 2022

TORONTO, ON / ACCESSWIRE / May 27, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research,...

IPCI.TO : 0.0800 (-11.11%)
IPCIF : 0.0001 (-99.93%)
Intellipharmaceutics Announces First Quarter 2022 Results ACCESS Newswire - Thu Apr 14, 2022

TORONTO, ON / ACCESSWIRE / April 14, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...

IPCI.TO : 0.0800 (-11.11%)
IPCIF : 0.0001 (-99.93%)
Intellipharmaceutics Announces Fiscal Year 2021 Results ACCESS Newswire - Mon Feb 28, 2022

TORONTO, ON / ACCESSWIRE / February 28, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...

IPCI.TO : 0.0800 (-11.11%)
IPCIF : 0.0001 (-99.93%)
Intellipharmaceutics Reports Director Election Results ACCESS Newswire - Fri Feb 4, 2022

TORONTO, ON / ACCESSWIRE / February 4, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...

IPCI.TO : 0.0800 (-11.11%)
IPCIF : 0.0001 (-99.93%)

Barchart Exclusives

Intel Is Back From the Brink, But It Only Gets Tougher From Here. How Should You Play INTC in 2026? Barchart - 6 minutes ago
Intel is looking up but faces more headwinds ahead. Here's what's next for Intel as the company prepares to report earnings late next week. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot